CompletedPhase 4NCT00360074
Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation
Studying Central congenital hypothyroidism
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital Freiburg
- Principal Investigator
- Prof Dr Martin Reincke, MDformer Medical Professor of University Hospital Freiburg
- Intervention
- Thyroxin, Triiodothyronine(drug)
- Enrollment
- 25 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2004 – 2007
Study locations (1)
- University Hospital Freiburg, Department of Medicine, Freiburg im Breisgau, Baden-Wurttemberg, Germany
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00360074 on ClinicalTrials.govOther trials for Central congenital hypothyroidism
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT06452823Efficacy and Safety of Catheter Ablation of Atrial Fibrillation in Patients With Thyroid Hormone StabilizationThe Second Affiliated Hospital of Jiaxing University
- RECRUITINGNCT06083636Improvement of Laboratory Diagnostics in Hypothyroid Patients Using LevothyroxineAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- RECRUITINGNCT05276856Recovery Rate in Secondary HypothyroidismNova Scotia Health Authority
- RECRUITINGNCT06728735Role of Next Generation Sequencing in the Etiological Diagnosis of Permanent Congenital Hypothyroidism With in Situ ThyroidIRCCS Azienda Ospedaliero-Universitaria di Bologna